In this study, we want to compare different combinations of drugs for patients with multiple myeloma who have not responded to previous treatment. We want to learn if an investigational medication may be beneficial for the treatment of multiple myeloma.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Samuel Rubinstein
LCCC - Clinical Trials
Clinical or Medical
Interventional
Blood Conditions
Cancer (Multiple Myeloma)
22-2031